Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 19 de 19
Filter
Add more filters










Publication year range
1.
Commun Biol ; 6(1): 528, 2023 05 16.
Article in English | MEDLINE | ID: mdl-37193826

ABSTRACT

The discovery and characterization of antigen-specific CD8+ T cell clonotypes typically involves the labor-intensive synthesis and construction of peptide-MHC tetramers. We adapt single-chain trimer (SCT) technologies into a high throughput platform for pMHC library generation, showing that hundreds can be rapidly prepared across multiple Class I HLA alleles. We use this platform to explore the impact of peptide and SCT template mutations on protein expression yield, thermal stability, and functionality. SCT libraries were an efficient tool for identifying T cells recognizing commonly reported viral epitopes. We then construct SCT libraries to capture SARS-CoV-2 specific CD8+ T cells from COVID-19 participants and healthy donors. The immunogenicity of these epitopes is validated by functional assays of T cells with cloned TCRs captured using SCT libraries. These technologies should enable the rapid analyses of peptide-based T cell responses across several contexts, including autoimmunity, cancer, or infectious disease.


Subject(s)
CD8-Positive T-Lymphocytes , COVID-19 , Humans , SARS-CoV-2/genetics , Antigens , Epitopes , Peptides/genetics
2.
Nature ; 615(7953): 697-704, 2023 03.
Article in English | MEDLINE | ID: mdl-36890230

ABSTRACT

Neoantigens are peptides derived from non-synonymous mutations presented by human leukocyte antigens (HLAs), which are recognized by antitumour T cells1-14. The large HLA allele diversity and limiting clinical samples have restricted the study of the landscape of neoantigen-targeted T cell responses in patients over their treatment course. Here we applied recently developed technologies15-17 to capture neoantigen-specific T cells from blood and tumours from patients with metastatic melanoma with or without response to anti-programmed death receptor 1 (PD-1) immunotherapy. We generated personalized libraries of neoantigen-HLA capture reagents to single-cell isolate the T cells and clone their T cell receptors (neoTCRs). Multiple T cells with different neoTCR sequences (T cell clonotypes) recognized a limited number of mutations in samples from seven patients with long-lasting clinical responses. These neoTCR clonotypes were recurrently detected over time in the blood and tumour. Samples from four patients with no response to anti-PD-1 also demonstrated neoantigen-specific T cell responses in the blood and tumour to a restricted number of mutations with lower TCR polyclonality and were not recurrently detected in sequential samples. Reconstitution of the neoTCRs in donor T cells using non-viral CRISPR-Cas9 gene editing demonstrated specific recognition and cytotoxicity to patient-matched melanoma cell lines. Thus, effective anti-PD-1 immunotherapy is associated with the presence of polyclonal CD8+ T cells in the tumour and blood specific for a limited number of immunodominant mutations, which are recurrently recognized over time.


Subject(s)
Antigens, Neoplasm , CD8-Positive T-Lymphocytes , Immune Checkpoint Inhibitors , Immunotherapy , Melanoma , Humans , Antigens, Neoplasm/immunology , CD8-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/metabolism , Melanoma/drug therapy , Melanoma/genetics , Melanoma/immunology , Melanoma/pathology , Receptors, Antigen, T-Cell/immunology , Receptors, Antigen, T-Cell/metabolism , Immune Checkpoint Inhibitors/pharmacology , Immune Checkpoint Inhibitors/therapeutic use , HLA Antigens/immunology , Neoplasm Metastasis , Precision Medicine , Gene Editing , CRISPR-Cas Systems , Mutation
3.
Nature ; 615(7953): 687-696, 2023 03.
Article in English | MEDLINE | ID: mdl-36356599

ABSTRACT

T cell receptors (TCRs) enable T cells to specifically recognize mutations in cancer cells1-3. Here we developed a clinical-grade approach based on CRISPR-Cas9 non-viral precision genome-editing to simultaneously knockout the two endogenous TCR genes TRAC (which encodes TCRα) and TRBC (which encodes TCRß). We also inserted into the TRAC locus two chains of a neoantigen-specific TCR (neoTCR) isolated from circulating T cells of patients. The neoTCRs were isolated using a personalized library of soluble predicted neoantigen-HLA capture reagents. Sixteen patients with different refractory solid cancers received up to three distinct neoTCR transgenic cell products. Each product expressed a patient-specific neoTCR and was administered in a cell-dose-escalation, first-in-human phase I clinical trial ( NCT03970382 ). One patient had grade 1 cytokine release syndrome and one patient had grade 3 encephalitis. All participants had the expected side effects from the lymphodepleting chemotherapy. Five patients had stable disease and the other eleven had disease progression as the best response on the therapy. neoTCR transgenic T cells were detected in tumour biopsy samples after infusion at frequencies higher than the native TCRs before infusion. This study demonstrates the feasibility of isolating and cloning multiple TCRs that recognize mutational neoantigens. Moreover, simultaneous knockout of the endogenous TCR and knock-in of neoTCRs using single-step, non-viral precision genome-editing are achieved. The manufacture of neoTCR engineered T cells at clinical grade, the safety of infusing up to three gene-edited neoTCR T cell products and the ability of the transgenic T cells to traffic to the tumours of patients are also demonstrated.


Subject(s)
Cell- and Tissue-Based Therapy , Gene Editing , Neoplasms , Precision Medicine , Receptors, Antigen, T-Cell , T-Lymphocytes , Transgenes , Humans , Antigens, Neoplasm/genetics , Antigens, Neoplasm/immunology , Biopsy , Cell- and Tissue-Based Therapy/adverse effects , Cell- and Tissue-Based Therapy/methods , Cytokine Release Syndrome/complications , Disease Progression , Encephalitis/complications , Gene Knock-In Techniques , Gene Knockout Techniques , Genes, T-Cell Receptor alpha , Genes, T-Cell Receptor beta , Mutation , Neoplasms/complications , Neoplasms/genetics , Neoplasms/immunology , Neoplasms/therapy , Patient Safety , Precision Medicine/adverse effects , Precision Medicine/methods , Receptors, Antigen, T-Cell/genetics , Receptors, Antigen, T-Cell/immunology , Receptors, Antigen, T-Cell/metabolism , T-Lymphocytes/immunology , T-Lymphocytes/metabolism , Transgenes/genetics , HLA Antigens/immunology , CRISPR-Cas Systems
4.
Res Sq ; 2022 Nov 18.
Article in English | MEDLINE | ID: mdl-36415462

ABSTRACT

CD8 + cytotoxic T cell responses against viral infection represent a major element of the adaptive immune response. We describe the development of a peptide antigen - major histompatibility complex (pMHC) library representing the full SARS-CoV-2 viral proteome, and comprised of 634 pMHC multimers representing the A*02.01, A*24.02, and B*07.02 HLA alleles, as well as specific antigens associated with the cytomegalovirus (CMV). These libraries were used to capture non-expanded CD8 + T cells from blood samples collected from 64 infected individuals, and then analyzed using single cell RNA-seq. The discovery and characterization of antigen-specific CD8 + T cell clonotypes typically involves the labor-intensive synthesis and construction of peptide-MHC tetramers. We adapted single-chain trimer (SCT) technologies into a high throughput platform for pMHC library generation, showing that hundreds can be rapidly prepared across multiple Class I HLA alleles. We used this platform to explore the impact of peptide and SCT template mutations on protein expression yield, thermal stability, and functionality. SCT libraries were an efficient tool for identifying T cells recognizing commonly reported viral epitopes. We then constructed SCT libraries designed to capture SARS-CoV-2 specific CD8 + T cells from COVID-19 participants and healthy donors. The immunogenicity of these epitopes was validated by functional assays of T cells with cloned TCRs captured using SCT libraries. These technologies should enable the rapid analyses of peptide-based T cell responses across several contexts, including autoimmunity, cancer, or infectious disease.

5.
Cell Rep ; 28(10): 2728-2738.e7, 2019 09 03.
Article in English | MEDLINE | ID: mdl-31484081

ABSTRACT

Neoantigen-specific T cells are increasingly viewed as important immunotherapy effectors, but physically isolating these rare cell populations is challenging. Here, we describe a sensitive method for the enumeration and isolation of neoantigen-specific CD8+ T cells from small samples of patient tumor or blood. The method relies on magnetic nanoparticles that present neoantigen-loaded major histocompatibility complex (MHC) tetramers at high avidity by barcoded DNA linkers. The magnetic particles provide a convenient handle to isolate the desired cell populations, and the barcoded DNA enables multiplexed analysis. The method exhibits superior recovery of antigen-specific T cell populations relative to literature approaches. We applied the method to profile neoantigen-specific T cell populations in the tumor and blood of patients with metastatic melanoma over the course of anti-PD1 checkpoint inhibitor therapy. We show that the method has value for monitoring clinical responses to cancer immunotherapy and might help guide the development of personalized mutational neoantigen-specific T cell therapies and cancer vaccines.


Subject(s)
Antigens, Neoplasm/blood , Melanoma/blood , Melanoma/immunology , T-Lymphocytes/immunology , Biopsy , HEK293 Cells , Humans , Immunotherapy , Jurkat Cells , Kinetics , Lymphocytes, Tumor-Infiltrating/immunology , Magnetite Nanoparticles/chemistry , Major Histocompatibility Complex , Melanoma/pathology , Melanoma/secondary , Nucleic Acids/metabolism , Programmed Cell Death 1 Receptor/immunology , Receptors, Antigen, T-Cell/metabolism , Reproducibility of Results , Tomography, X-Ray Computed
6.
Lab Chip ; 19(18): 3011-3021, 2019 09 10.
Article in English | MEDLINE | ID: mdl-31502632

ABSTRACT

Adaptive immunity is based on peptide antigen recognition. Our ability to harness the immune system for therapeutic gain relies on the discovery of the T cell receptor (TCR) genes that selectively target antigens from infections, mutated proteins, and foreign agents. Here we present a method that selectively labels peptide antigen-specific CD8+ T cells using magnetic nanoparticles functionalized with peptide-MHC tetramers, isolates these specific cells within an integrated microfluidic device, and directly amplifies the TCR genes for sequencing. Critically, the identity of the peptide recognized by the TCR is preserved, providing the link between peptide and gene. The platform requires inputs on the order of just 100 000 CD8+ T cells, can be multiplexed for simultaneous analysis of multiple peptides, and performs sorting and isolation on chip. We demonstrate 1000-fold sensitivity enhancement of detecting antigen-specific TCRs relative to bulk analysis and simultaneous capture of two virus antigen-specific TCRs from a population of T cells.


Subject(s)
Antigens/genetics , Microfluidic Analytical Techniques , Receptors, Antigen, T-Cell/genetics , CD8-Positive T-Lymphocytes , Cells, Cultured , Humans , Magnetite Nanoparticles/chemistry , Microfluidic Analytical Techniques/instrumentation , Particle Size , Reverse Transcriptase Polymerase Chain Reaction
7.
Nat Methods ; 16(2): 191-198, 2019 02.
Article in English | MEDLINE | ID: mdl-30700902

ABSTRACT

CD8+ T cells recognize and eliminate tumors in an antigen-specific manner. Despite progress in characterizing the antitumor T cell repertoire and function, the identification of target antigens remains a challenge. Here we describe the use of chimeric receptors called signaling and antigen-presenting bifunctional receptors (SABRs) in a cell-based platform for T cell receptor (TCR) antigen discovery. SABRs present an extracellular complex comprising a peptide and major histocompatibility complex (MHC), and induce intracellular signaling via a TCR-like signal after binding with a cognate TCR. We devised a strategy for antigen discovery using SABR libraries to screen thousands of antigenic epitopes. We validated this platform by identifying the targets recognized by public TCRs of known specificities. Moreover, we extended this approach for personalized neoantigen discovery.


Subject(s)
Antigen Presentation , Receptors, Antigen, T-Cell/metabolism , Signal Transduction , Antigen-Presenting Cells/cytology , Antigens/chemistry , Antigens, CD/metabolism , Antigens, Differentiation, T-Lymphocyte/metabolism , CD8-Positive T-Lymphocytes/cytology , Cloning, Molecular , Coculture Techniques , Epitopes/chemistry , False Positive Reactions , Gene Library , Green Fluorescent Proteins/metabolism , HEK293 Cells , Humans , Immunotherapy/methods , Jurkat Cells , K562 Cells , Lectins, C-Type/metabolism , Major Histocompatibility Complex , Oligonucleotides/genetics , Peptides/chemistry
8.
Nat Methods ; 16(2): 183-190, 2019 02.
Article in English | MEDLINE | ID: mdl-30700903

ABSTRACT

T cell receptor (TCR) ligand discovery is essential for understanding and manipulating immune responses to tumors. We developed a cell-based selection platform for TCR ligand discovery that exploits a membrane transfer phenomenon called trogocytosis. We discovered that T cell membrane proteins are transferred specifically to target cells that present cognate peptide-major histocompatibility complex (MHC) molecules. Co-incubation of T cells expressing an orphan TCR with target cells collectively presenting a library of peptide-MHCs led to specific labeling of cognate target cells, enabling isolation of these target cells and sequencing of the cognate TCR ligand. We validated this method for two clinically employed TCRs and further used the platform to identify the cognate neoepitope for a subject-derived neoantigen-specific TCR. Thus, target cell trogocytosis is a robust tool for TCR ligand discovery that will be useful for studying basic tumor immunology and identifying new targets for immunotherapy.


Subject(s)
Antigens/chemistry , Genetic Techniques , Receptors, Antigen, T-Cell/chemistry , T-Lymphocytes/cytology , Adaptive Immunity , Animals , Biotinylation , DNA/analysis , Epitopes/chemistry , Gene Library , HEK293 Cells , Humans , Immunotherapy , Jurkat Cells , K562 Cells , Ligands , Mice , Peptides/chemistry , Phagocytosis , T-Lymphocytes/immunology
9.
Exp Ther Med ; 16(3): 1655-1662, 2018 Sep.
Article in English | MEDLINE | ID: mdl-30186384

ABSTRACT

The advantages of combining local delivery of bone morphogenetic protein (BMP)-2 with systemic or local anti-osteoporosis treatments have also been studied for enhancing osteoporotic fracture healing. The aim of the present study was to evaluate the effect of combination therapy with BMP-2 and psoralen on fracture repair in ovariectomized mice. At 6 weeks after bilateral ovariectomy, mice (n=30) underwent unilateral transverse osteotomy on the femur and were divided into 3 groups. In the model group (n=10), animals were implanted with an absorbable collagen sponge (ACS) alone and administered physiological saline intragastrically (i.g.). In the recombinant human (rh)BMP-2 group (n=10), animals were implanted with an ACS loaded with 2.5 µg rhBMP-2 and administered physiological saline i.g. In the psoralen + rhBMP-2 group (n=10) animals were implanted with an ACS loaded with 2.5 µg rhBMP-2 and administered psoralen i.g. The mice were euthanized after 21 days and their fractured femurs were assessed by micro computed tomography, histological analysis and biomechanical testing. Furthermore, the serum of the animals was analyzed. Psoralen + rhBMP-2 exerted more beneficial effects on callus consolidation and biomechanical strength. In addition, increased bone-specific alkaline phosphatase levels and decreased C-terminal telopeptide of type-1 collagen were observed in the Psoralen + rhBMP-2 group. However, no difference in estrogen levels was detected between the groups. In conclusion, the present study demonstrated that in ovariectomized mice, combination of locally delivered BMP-2 and systemically administered psoralen improved bone healing compared with BMP-2 alone.

10.
Nanoscale ; 9(21): 6953-6958, 2017 Jun 01.
Article in English | MEDLINE | ID: mdl-28451677

ABSTRACT

Bio-interface transistors, which manipulate the transportation of ions (i.e. protons), play an important role in bridging physical devices with biological functionalities, because electrical signals are carried by ions/protons in biological systems. All available ionic transistors use electrostatic gates to tune the ionic carrier density, which requires complicated interconnect wires. In contrast, an optical gate, which offers the advantages of remote control as well as multiple light wavelength selections, has never been explored for ionic devices. Here, we demonstrate a light-gated protonic transistor fabricated from an Au nanoparticle and DNA (AuNP-DNA) hybrid membrane. The device can be turned on and off completely by using light, with a high on/off current ratio of up to 2 orders of magnitude. Moreover, the device only responds to specific light wavelengths due to the plasmonic effect from the AuNPs, which enables the capability of wavelength selectivity. Our results open up new avenues for exploring remotely controlled ionic circuits, in vivo protonic switches, and other biomedical applications.


Subject(s)
DNA/chemistry , Gold , Metal Nanoparticles/chemistry , Transistors, Electronic , Ions , Protons
11.
Springerplus ; 5(1): 1923, 2016.
Article in English | MEDLINE | ID: mdl-27917329

ABSTRACT

OBJECTIVE: The aim of this study was to evaluate the clinical outcome of tibial pilon fractures treated with arthroscopy and assisted reduction with an external fixator. METHODS: Thirteen patients with tibial pilon fractures underwent assisted reduction for limited lower internal fixation with an external fixator under arthroscopic guidance. The weight-bearing time was decided on the basis of repeat radiography of the tibia 3 months after surgery. Postoperative ankle function was evaluated according to the Mazur scoring system. RESULTS: Healing of fractures was achieved in all cases, with no complications such as severe infection, skin necrosis, or an exposed plate. There were 9 excellent, 2 good, and 2 poor outcomes, scored according to the Mazur system. The acceptance rate was 85%. CONCLUSION: Arthroscopy and external fixator-assisted reduction for the minimally invasive treatment of tibial pilon fractures not only produced less trauma but also protected the soft tissues and blood supply surrounding the fractures. External fixation could indirectly provide reduction and effective operative space for arthroscopic implantation, especially for AO type B fractures and partial AO type C1 fractures.

12.
Biomacromolecules ; 17(6): 2019-26, 2016 06 13.
Article in English | MEDLINE | ID: mdl-27112709

ABSTRACT

Protein expression and selection is an essential process in the modification of biological products. Expressed proteins are selected based on desired traits (phenotypes) from diverse gene libraries (genotypes), whose size may be limited due to the difficulties inherent in diverse cell preparation. In addition, not all genes can be expressed in cells, and linking genotype with phenotype further presents a great challenge in protein engineering. We present a DNA gel-based platform that demonstrates the versatility of two DNA microgel formats to address fundamental challenges of protein engineering, including high protein yield, isolation of gene sets, and protein display. We utilize microgels to show successful protein production and capture of a model protein, green fluorescent protein (GFP), which is further used to demonstrate a successful gene enrichment through fluorescence-activated cell sorting (FACS) of a mixed population of microgels containing the GFP gene. Through psoralen cross-linking of the hydrogels, we have synthesized DNA microgels capable of surviving denaturing conditions while still possessing the ability to produce protein. Lastly, we demonstrate a method of producing extremely high local gene concentrations of up to 32 000 gene repeats in hydrogels 1 to 2 µm in diameter. These DNA gels can serve as a novel cell-free platform for integrated protein expression and display, which can be applied toward more powerful, scalable protein engineering and cell-free synthetic biology with no physiological boundaries and limitations.


Subject(s)
DNA/chemistry , Hydrogels/chemistry , Protein Engineering , Recombinant Proteins/genetics , Cross-Linking Reagents/chemistry , DNA/genetics , Dimethylpolysiloxanes/chemistry , Escherichia coli/genetics , Ficusin/chemistry , Green Fluorescent Proteins/genetics , Hydrogels/chemical synthesis , Plasmids , Protein Biosynthesis/genetics
13.
Sci Rep ; 3: 3165, 2013 Nov 07.
Article in English | MEDLINE | ID: mdl-24196527

ABSTRACT

In most contemporary life forms, the confinement of cell membranes provides localized concentration and protection for biomolecules, leading to efficient biochemical reactions. Similarly, confinement may have also played an important role for prebiotic compartmentalization in early life evolution when the cell membrane had not yet formed. It remains an open question how biochemical reactions developed without the confinement of cell membranes. Here we mimic the confinement function of cells by creating a hydrogel made from geological clay minerals, which provides an efficient confinement environment for biomolecules. We also show that nucleic acids were concentrated in the clay hydrogel and were protected against nuclease, and that transcription and translation reactions were consistently enhanced. Taken together, our results support the importance of localized concentration and protection of biomolecules in early life evolution, and also implicate a clay hydrogel environment for biochemical reactions during early life evolution.


Subject(s)
Aluminum Silicates/chemistry , Evolution, Chemical , Hydrogel, Polyethylene Glycol Dimethacrylate/chemistry , Clay , DNA/metabolism , Deoxyribonucleases/metabolism , RNA/metabolism , Ribonucleases/metabolism
14.
J Am Chem Soc ; 135(38): 14008-11, 2013 Sep 25.
Article in English | MEDLINE | ID: mdl-23978265

ABSTRACT

Protein immune detection requires secondary antibodies which must be carefully selected in order to avoid interspecies cross-reactivity, and is therefore restricted by the limited availability of primary/secondary antibody pairs. Here we present a versatile DNA-based protein detection system using a universal adapter to interface between IgG antibodies and DNA-modified reporter molecules. As a demonstration of this capability, we successfully used DNA nano-barcodes, quantum dots, and horseradish peroxidase enzyme to detect multiple proteins using our DNA-based labeling system. Our system not only eliminates secondary antibodies but also serves as a novel method platform for protein detection with modularity, high capacity, and multiplexed capability.


Subject(s)
DNA/chemistry , Immunoglobulin G/chemistry , Nanostructures , Proteins/analysis , Fluorescent Dyes , Horseradish Peroxidase/chemistry , In Situ Hybridization, Fluorescence , Indicators and Reagents , Oligonucleotides/chemistry , Proteins/immunology , Quantum Dots
15.
Langmuir ; 29(27): 8665-74, 2013 Jul 09.
Article in English | MEDLINE | ID: mdl-23750547

ABSTRACT

Surface tension and gravity, whose influence on the deformation of conventional engineering materials is negligible, become important for soft materials that are typically used in the microfabrication of devices such as microfluidic channels. Although for soft materials the shape change due to these forces can be large, it is often neglected in the design processes. To capture conditions under which the influence of these forces is important, we propose a deformation map in which the shape change is captured by two dimensionless material parameters. Our idea is demonstrated by simulating the large deformation of a short circular cylinder made of a neo-Hookean material in frictionless contact with a rigid substrate. These simulations are carried out using a finite element model that accounts for surface tension and gravity. Our model integrates the two different approaches typically used to determine the shape change of solids and liquid drops in contact with a substrate.


Subject(s)
Elastomers/chemistry , Hydrogels/chemistry , Particle Size , Surface Tension
16.
Nat Nanotechnol ; 7(12): 816-20, 2012 Dec.
Article in English | MEDLINE | ID: mdl-23202472

ABSTRACT

Metamaterials are artificial substances that are structurally engineered to have properties not typically found in nature. To date, almost all metamaterials have been made from inorganic materials such as silicon and copper, which have unusual electromagnetic or acoustic properties that allow them to be used, for example, as invisible cloaks, superlenses or super absorbers for sound. Here, we show that metamaterials with unusual mechanical properties can be prepared using DNA as a building block. We used a polymerase enzyme to elongate DNA chains and weave them non-covalently into a hydrogel. The resulting material, which we term a meta-hydrogel, has liquid-like properties when taken out of water and solid-like properties when in water. Moreover, upon the addition of water, and after complete deformation, the hydrogel can be made to return to its original shape. The meta-hydrogel has a hierarchical internal structure and, as an example of its potential applications, we use it to create an electric circuit that uses water as a switch.


Subject(s)
Biocompatible Materials/chemical synthesis , DNA/chemical synthesis , Hydrogels/chemical synthesis , Nanostructures/chemistry , Biotechnology/methods , DNA Primers/metabolism , Nanotechnology/methods , Polymers/chemistry
17.
Biotechnol Bioeng ; 109(9): 2173-8, 2012 Sep.
Article in English | MEDLINE | ID: mdl-22488418

ABSTRACT

We present a novel method for testing drug permeability that features human cells cultured on hydrogel scaffolds made to accurately replicate the shape and size of human small intestinal villi. We compared villous scaffolds to more conventional 2D cultures in paracellular drug absorption and cell growth experiments. Our results suggest that 3D villous platforms facilitate cellular differentiation and absorption more similar to mammalian intestines than can be achieved using conventional culture. To the best of our knowledge, this is the first accurate 3D villus model offering a well-controlled microenvironment that has strong physiological relevance to the in vivo system.


Subject(s)
Artificial Organs , Cell Culture Techniques/instrumentation , Intestinal Mucosa/anatomy & histology , Intestinal Mucosa/metabolism , Intestine, Small/metabolism , Pharmacokinetics , Caco-2 Cells , Cell Culture Techniques/methods , Humans , Intestinal Absorption , Intestinal Mucosa/cytology , Intestine, Small/cytology , Microvilli/metabolism
18.
Nat Commun ; 2: 578, 2011 Dec 06.
Article in English | MEDLINE | ID: mdl-22146397

ABSTRACT

The challenge for new biosensors is to achieve detection of biomolecules at low concentrations, which is useful for early-stage disease detection. Nanomechanical biosensors are promising in medical diagnostic applications. For nanomechanical biosensing at low concentrations, a sufficient resonator device surface area is necessary for molecules to bind to. Here we present a low-concentration (500 aM sensitivity) DNA sensor, which uses a novel nanomechanical resonator with ordered vertical nanowire arrays on top of a Si/SiO(2) bilayer thin membrane. The high sensitivity is achieved by the strongly enhanced total surface area-to-volume ratio of the resonator (10(8) m(-1)) and the state-of-the-art mass-per-area resolution (1.8×10(-12) kg m(-2)). Moreover, the nanowire array forms a photonic crystal that shows strong light trapping and absorption over broad-band optical wavelengths, enabling high-efficiency broad-band opto-thermo-mechanical remote device actuation and biosensing on a chip. This method represents a mass-based platform technology that can sense molecules at low concentrations.


Subject(s)
Biosensing Techniques/methods , DNA Probes/chemistry , DNA/analysis , Nanotechnology/methods , Biosensing Techniques/instrumentation , Crystallization , Equipment Design , Nanotechnology/instrumentation , Nanowires/chemistry , Optical Devices , Photochemistry , Photons , Sensitivity and Specificity , Silicon Dioxide/chemistry
19.
Chem Soc Rev ; 40(12): 5730-44, 2011 Dec.
Article in English | MEDLINE | ID: mdl-21858293

ABSTRACT

While DNA is a genetic material, it is also an inherently polymeric material made from repeating units called nucleotides. Although DNA's biological functions have been studied for decades, the polymeric features of DNA have not been extensively exploited until recently. In this tutorial review, we focus on two aspects of using DNA as a polymeric material: (1) the engineering methods, and (2) the potential real-world applications. More specifically, various strategies for constructing DNA-based building blocks and materials are introduced based on DNA topologies, which include linear, branched/dendritic, and networked. Different applications in nanotechnology, medicine, and biotechnology are further reviewed.


Subject(s)
Bioengineering/methods , DNA , Animals , Base Sequence , DNA/chemistry , DNA/genetics , Dendrimers/chemistry , Nanotechnology
SELECTION OF CITATIONS
SEARCH DETAIL
...